2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow ACAM2000: new trials by email Literature Review of ACAM2000 trials Research Report on ACAM2000
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000® MVA BN®, ACAM2000® - 18-42 Year Old Healthy Vaccinia-naïve Subjects | Phase 3 | Completed | Bavarian Nordic | 440 | 2015-03-01 | 2019-12-05 |
| VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV ACAM2000 - Smallpox Vaccine Adverse Reaction | Phase 3 | Completed | Emergent BioSolutions | 25 | 2010-09-13 | 2024-03-18 |
Bavarian Nordic (1) · Emergent BioSolutions (1)
South Korea (1) · United States (1)
Phillip R Pittman, MD, MPH (1) · Ronald Brown, MD (1)